PRELUDE CAPITAL MANAGEMENT, LLC - NUVATION BIO INC ownership

NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 128 filers reported holding NUVATION BIO INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of NUVATION BIO INC
ValueSharesWeighting
Q3 2023$44,129
-62.6%
32,932
-49.7%
0.00%
-62.5%
Q2 2023$117,907
-3.7%
65,504
-11.2%
0.01%
+14.3%
Q1 2023$122,467
-16.3%
73,775
-3.2%
0.01%
-12.5%
Q4 2022$146,312
+24.0%
76,204
+44.6%
0.01%
+100.0%
Q3 2022$118,000
-11.3%
52,704
+313.0%
0.00%
+33.3%
Q1 2021$133,00012,7620.00%
Other shareholders
NUVATION BIO INC shareholders Q4 2022
NameSharesValueWeighting ↓
Omega Fund Management, LLC 15,072,340$27,130,21215.20%
Aisling Capital Management LP 2,541,009$4,573,8162.24%
EDBI Pte Ltd 1,270,504$2,286,9071.85%
Deep Track Capital, LP 7,720,688$13,897,2380.64%
EcoR1 Capital, LLC 13,896,543$25,013,7770.61%
Prosight Management, LP 2,200,000$3,960,0000.59%
AWM Investment Company, Inc. 1,425,000$2,565,0000.35%
AlphaCentric Advisors LLC 345,000$621,0000.34%
Acuitas Investments, LLC 316,517$569,7310.33%
BRAIDWELL LP 4,122,900$7,421,2200.24%
View complete list of NUVATION BIO INC shareholders